标题
Harnessing TH9 cells in cancer immunotherapy
作者
关键词
Cancer, Immunotherapy, T cell, Adoptive T cell transfer, Immune checkpoints, Immunomodulation
出版物
SEMINARS IN IMMUNOLOGY
Volume -, Issue -, Pages 101477
出版商
Elsevier BV
发表日期
2021-04-21
DOI
10.1016/j.smim.2021.101477
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Multifaceted Role of Th1, Th9, and Th17 Cells in Immune Checkpoint Inhibition Therapy
- (2021) Jongdae Lee et al. Frontiers in Immunology
- Targeting the IL-9 pathway in cancer immunotherapy
- (2020) Ningbo Zheng et al. Human Vaccines & Immunotherapeutics
- Anticancer effects of the microbiota: how the microbiome shapes the development of IL-9-producing T cells
- (2020) Lionel Apetoh BRITISH JOURNAL OF CANCER
- Host dysbiosis negatively impacts IL-9-producing T-cell differentiation and antitumour immunity
- (2020) Rafael Ribeiro Almeida et al. BRITISH JOURNAL OF CANCER
- Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer
- (2020) Ylia Salazar et al. JOURNAL OF CLINICAL INVESTIGATION
- cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity
- (2020) Stephen T. Ferris et al. NATURE
- Proteome analysis revealed the essential functions of protein phosphatase PP2A in the induction of Th9 cells
- (2020) Suyasha Roy et al. Scientific Reports
- Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint Inhibitors
- (2020) Magalie Dosset et al. Cells
- STAT5 promotes accessibility and is required for BATF-mediated plasticity at the Il9 locus
- (2020) Yongyao Fu et al. Nature Communications
- Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9
- (2020) Lintao Liu et al. Nature Communications
- TNF-α enhances Th9 cell differentiation and antitumor immunity via TNFR2-dependent pathways
- (2019) Yuxue Jiang et al. Journal for ImmunoTherapy of Cancer
- GM-CSF Promotes Antitumor Immunity by Inducing Th9 Cell Responses
- (2019) Il-Kyu Kim et al. Cancer Immunology Research
- IL-4 together with IL-1β induces antitumor Th9 cell differentiation in the absence of TGF-β signaling
- (2019) Gang Xue et al. Nature Communications
- Functional systemic CD4 immunity is required for clinical responses to PD‐L1/PD‐1 blockade therapy
- (2019) Miren Zuazo et al. EMBO Molecular Medicine
- Fas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions
- (2019) Yingying Shen et al. Nature Communications
- Th9 cells are subjected to PD-1/PD-L1-mediated inhibition and are capable of promoting CD8 T cell expansion through IL-9R in colorectal cancer
- (2019) Chenfei Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- CD4+ T Cell Help Is Required for the Formation of a Cytolytic CD8+ T Cell Subset that Protects against Chronic Infection and Cancer
- (2019) Ryan Zander et al. IMMUNITY
- CD4+ T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 Therapy
- (2019) Hiroshi Kagamu et al. Cancer Immunology Research
- Th9 Cells Represent a Unique Subset of CD4 + T Cells Endowed with the Ability to Eradicate Advanced Tumors
- (2018) Yong Lu et al. CANCER CELL
- Prospective analysis of adoptive TIL therapy in patients with metastatic melanoma: response, impact of anti-CTLA4, and biomarkers to predict clinical outcome
- (2018) Marie-Andrée Forget et al. CLINICAL CANCER RESEARCH
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- Transcriptional Control of Th9 Cells: Role of Foxo1 in Interleukin-9 Induction
- (2018) Sakshi Malik et al. Frontiers in Immunology
- Interleukin-33 Contributes to the Induction of Th9 Cells and Antitumor Efficacy by Dectin-1-Activated Dendritic Cells
- (2018) Jintong Chen et al. Frontiers in Immunology
- Th9 cells promote antitumor immunity via IL-9 and IL-21 and demonstrate atypical cytokine expression in breast cancer
- (2017) Fa-Ping You et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Specifically differentiated T cell subset promotes tumor immunity over fatal immunity
- (2017) Abdulraouf Ramadan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of TH9 cells programmed by IL-7
- (2017) Enguang Bi et al. Science Signaling
- Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells
- (2017) Thaiz Rivera Vargas et al. Nature Communications
- Transcription factor Foxo1 is essential for IL-9 induction in T helper cells
- (2017) Sakshi Malik et al. Nature Communications
- IRF8-dependent molecular complexes control the Th9 transcriptional program
- (2017) Etienne Humblin et al. Nature Communications
- Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of TH9 cells programmed by IL-7
- (2017) Enguang Bi et al. Science Signaling
- IL-9 promotes the survival and function of human melanoma-infiltrating CD4+CD8+double-positive T cells
- (2016) Tiphaine Parrot et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Histone Deacetylase SIRT1 Negatively Regulates the Differentiation of Interleukin-9-Producing CD4 + T Cells
- (2016) Yu Wang et al. IMMUNITY
- Induction of antigen-specific TH9 immunity accompanied by mast cell activation blocks tumor cell engraftment
- (2016) Aws Abdul-Wahid et al. INTERNATIONAL JOURNAL OF CANCER
- Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells
- (2016) Yinghua Zhao et al. Nature Communications
- Induction of specific T helper-9 cells to inhibit glioma cell growth
- (2016) Haiyan Zheng et al. Oncotarget
- Peripheral blood Th9 cells are a possible pharmacodynamic biomarker of nivolumab treatment efficacy in metastatic melanoma patients
- (2016) Yumi Nonomura et al. OncoImmunology
- Inhibition of squamous cancer growth in a mouse model by Staphylococcal enterotoxin B-triggered Th9 cell expansion
- (2015) Bei-Ping Miao et al. Cellular & Molecular Immunology
- The DNA-binding inhibitor Id3 regulates IL-9 production in CD4+ T cells
- (2015) Hiroko Nakatsukasa et al. NATURE IMMUNOLOGY
- Glucocorticoid-induced tumor necrosis factor receptor–related protein co-stimulation facilitates tumor regression by inducing IL-9–producing helper T cells
- (2015) Il-Kyu Kim et al. NATURE MEDICINE
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- GITR subverts Foxp3+ Tregs to boost Th9 immunity through regulation of histone acetylation
- (2015) Xiang Xiao et al. Nature Communications
- Consensus nomenclature for CD8+T cell phenotypes in cancer
- (2015) Lionel Apetoh et al. OncoImmunology
- Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy
- (2014) Jungsun Park et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells
- (2014) Frédérique Végran et al. NATURE IMMUNOLOGY
- Human TH9 Cells Are Skin-Tropic and Have Autocrine and Paracrine Proinflammatory Capacity
- (2014) C. Schlapbach et al. Science Translational Medicine
- SOCS3 Transactivation by PPAR Prevents IL-17-Driven Cancer Growth
- (2013) H. Berger et al. CANCER RESEARCH
- Differentiation and Immune Regulation of IL-9−Producing CD4+T Cells in Malignant Pleural Effusion
- (2012) Zhi-Jian Ye et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- mTOR, metabolism, and the regulation of T-cell differentiation and function
- (2012) Adam T. Waickman et al. IMMUNOLOGICAL REVIEWS
- Th9 cells promote antitumor immune responses in vivo
- (2012) Yong Lu et al. JOURNAL OF CLINICAL INVESTIGATION
- OX40 signaling favors the induction of TH9 cells and airway inflammation
- (2012) Xiang Xiao et al. NATURE IMMUNOLOGY
- Robust tumor immunity to melanoma mediated by interleukin-9–producing T cells
- (2012) Rahul Purwar et al. NATURE MEDICINE
- Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity?
- (2012) François Martin et al. TRENDS IN MOLECULAR MEDICINE
- Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature
- (2011) Pawel Muranski et al. IMMUNITY
- The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation
- (2010) Hua-Chen Chang et al. NATURE IMMUNOLOGY
- IL-9 as a mediator of Th17-driven inflammatory disease
- (2009) Elizabeth C. Nowak et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
- (2009) Lin Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9–producing subset
- (2008) Marc Veldhoen et al. NATURE IMMUNOLOGY
- IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3− effector T cells
- (2008) Valérie Dardalhon et al. NATURE IMMUNOLOGY
- Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1
- (2008) Naomi N. Hunder et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started